This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Other and unspecified parts of small intestine
CD2_BENIGN_SMALL_INTESTINE_OTH_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum partis aliae sive non specificatae intestini
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other and unspecified parts of small intestine
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Other and unspecified parts of small intestine
- Benign neoplasm: Small intestine
- Benign neoplasm: Small intestine
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 556 | 344 | 212 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | 60.31 | 58.29 | 63.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 507
- Matched controls
- 5069
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
323.0
480
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
12.9
144.2
387
1014
130
Kela drug reimbursment
Malignant tumour
+∞
59.6
56
*
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
44.7
45.8
56
14
Z71.9
ICD-10 Finland
Counselling, unspecified
9.3
45.5
100
130
SPAT1236
SPAT
Informing family of child’s disability
18.6
45.4
71
44
UJF32
NOMESCO Finland
Coloscopy
4.0
43.7
233
880
Z51.88
ICD-10 Finland
Other specified medical care
20.5
39.9
60
33
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
28.2
37.5
51
20
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
13.6
36.9
65
54
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
10.6
36.5
73
79
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
99.6
34.2
37
*
JN4BD
NOMESCO Finland
Extensive body CT
7.5
33.0
82
127
C61
ICD-10 Finland
Malignant neoplasm of prostate
344.2
32.2
32
*
Z26.9
ICD-10 Finland
Need for immunization against unspecified infectious disease
16.4
32.1
52
35
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
31.6
30
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
5.4
31.1
101
222
Z50.1
ICD-10 Finland
Other physical therapy
6.6
31.0
84
147
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.1
30.8
245
1173
JFB00
NOMESCO Finland
Partial resection of small intestine
21.8
30.1
44
22
A03FA01
ATC
metoclopramide; systemic, rectal
4.4
29.7
122
343
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
28.4
27
*
UJF92
NOMESCO Finland
Capsular endoscopy
13.8
28.2
49
39
A04AA02
ATC
granisetron; systemic, transdermal
153.4
27.9
29
*
WZC30
SPAT
NA
12.2
26.7
49
44
H02AB02
ATC
dexamethasone; systemic
19.6
26.6
40
22
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
26.3
25
*
Z01.7
ICD-10 Finland
Laboratory examination
4.2
25.8
109
311
UJF30
NOMESCO Finland
Ileoscopy through colon
4.6
25.6
96
244
A02BC05
ATC
esomeprazole; systemic
2.6
23.4
262
1469
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.9
23.3
27
5
UJF02
NOMESCO Finland
Peroral enteroscopy
68.3
23.0
26
*
ZX120
NOMESCO Finland
Intravenous
5.0
23.0
78
177
Z25.1
ICD-10 Finland
Need for immunization against influenza
5.6
22.9
70
141
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
20.2
22.9
34
18
Z01.3
ICD-10 Finland
Examination of blood pressure
14.6
22.6
38
28
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.2
22.6
92
252
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
3.9
22.4
100
297
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
21.7
163
713
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.6
21.4
78
191
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
80.3
20.8
23
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.6
20.5
45
57
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.1
20.3
43
51
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
19.9
161
731
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
76.6
19.8
22
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.7
19.7
71
171
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.6
19.7
97
312
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
41.9
19.7
24
6
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.4
19.5
74
188
Z3231
NOMESCO Finland
Registered nurse
2.6
19.4
174
837
Z2221
NOMESCO Finland
Medical doctor
2.6
19.4
180
885
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
12.0
19.3
35
31
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
15.6
19.2
31
21
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
18.9
18
*
R4110
NOMESCO Finland
Physiotherapy
2.6
18.6
165
784
A02BC02
ATC
pantoprazole; systemic
2.4
18.5
363
2591
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
26.2
18.4
25
10
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.8
17
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
A02BC01
ATC
omeprazole; systemic
2.5
17.8
188
981
PJA12
NOMESCO Finland
Sentinel node biopsy
186.2
17.6
18
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
17.4
87
281
Z3226
NOMESCO Finland
Physiotherapist
2.8
17.0
128
547
B01AB05
ATC
enoxaparin; parenteral
2.4
16.5
177
925
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
16.4
138
631
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.4
15.9
59
146
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
13.5
15.8
27
21
L03AA13
ATC
pegfilgrastim; parenteral
+∞
15.7
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.7
15
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.6
15.1
44
84
WW500
NOMESCO Finland
Blood transfusion
9.1
14.9
31
36
WF002
NOMESCO Finland
Radical radiotherapy
58.5
14.9
17
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.4
14.9
35
50
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
19.1
14.8
22
12
L01BC06
ATC
capecitabine; oral
+∞
14.6
14
*
L02BG04
ATC
letrozole; oral
37.2
14.5
18
5
L03AA02
ATC
filgrastim; parenteral
37.2
14.5
18
5
OAB50
SPAT
NA
11.8
14.4
26
23
SPAT1285
SPAT
Provision of consultation response
4.2
14.3
56
146
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
14.3
126
587
A02BA02
ATC
ranitidine; systemic
2.4
14.2
140
689
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
5.1
14.2
45
95
N02AA05
ATC
oxycodone; systemic
3.0
13.9
84
311
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.8
13.8
39
72
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
13.6
13
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
13.6
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
143.7
13.5
14
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
13.1
90
360
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
11.4
13.1
24
22
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
13.1
107
476
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
12.9
111
508
B03BA03
ATC
hydroxocobalamin; parenteral
3.7
12.9
58
172
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
12.8
112
513
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.1
12.8
73
259
L02BA01
ATC
tamoxifen; oral
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
12.5
83
325
JAH01
NOMESCO Finland
Laparoscopy
5.4
12.4
37
73
XF404
NOMESCO Finland
Ambulatory ECG
3.0
12.2
75
280
Z2446
NOMESCO Finland
Social worker
4.1
12.1
47
122
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
12.0
159
890
K29.4
ICD-10 Finland
Chronic atrophic gastritis
5.6
11.9
34
64
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
11.7
207
1301
A04AA01
ATC
ondansetron; systemic, rectal
6.4
11.7
30
49
K56.7
ICD-10 Finland
Ileus, unspecified
11.5
11.6
21
19
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
23.5
11.6
16
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.6
11.6
23
25
N02AX02
ATC
tramadol; systemic, rectal
1.9
11.5
235
1559
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
11.5
11
*
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
11.5
11
*
JDH05
NOMESCO Finland
Endoscopic polypectomy in duodenum
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
H01CB02
ATC
octreotide; parenteral
122.7
11.5
12
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
11.2
443
3768
UKC02
NOMESCO Finland
Cystoscopy
2.5
11.0
97
446
J01MA12
ATC
levofloxacin; systemic
2.3
11.0
112
551
SPAT1324
SPAT
Screening procedure
2.5
11.0
95
433
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
44.3
11.0
13
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.3
11.0
55
178
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
10.9
101
475
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.4
10.9
28
46
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
10.9
40
99
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
10.8
65
238
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
10.6
187
1164
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.6
211
1374
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.5
10.5
37
88
HAC20
NOMESCO Finland
Total mastectomy
112.2
10.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
10.4
10
*
189
Kela drug reimbursment
Imatinib
+∞
10.4
10
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
33.3
10.4
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.2
10.4
122
642
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.2
10.3
38
95
A09AA02
ATC
multienzymes (lipase, protease etc.)
15.0
10.1
16
11
UJD02
NOMESCO Finland
Gastroscopy
3.7
10.0
44
128
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.6
10.0
34
78
107
Kela drug reimbursment
Pernicious anaemia
5.3
9.8
29
57
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
20.5
9.8
14
7
JFB20
NOMESCO Finland
Ileocaecal resection
56.1
9.7
11
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
11.7
9.6
17
15
WZC00
SPAT
NA
4.4
9.6
34
82
XF402
NOMESCO Finland
ECG with work load test
2.4
9.5
83
377
JAH00
NOMESCO Finland
Laparotomy
6.8
9.5
23
35
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
101.8
9.4
10
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
101.8
9.4
10
*
JFA05
NOMESCO Finland
Endoscopic polypectomy in small intestine
101.8
9.4
10
*
R52.9
ICD-10 Finland
Pain, unspecified
2.8
9.4
60
229
WX402
NOMESCO Finland
General anaesthesia
2.5
9.4
75
326
2112X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Duodenum, jejunum and ileum[NEOPLASMA BENIGNUM ALIUD INTESTINI TENUIS, DUOD INC]
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
9.4
9
*
L01XE01
ATC
[U] imatinib; oral
+∞
9.4
9
*
L02AE02
ATC
leuprorelin; implant, parenteral
22.2
9.4
13
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
9.4
179
1136
J01DB01
ATC
cefalexin; oral
2.0
9.3
406
3394
P01AB01
ATC
metronidazole; oral, rectal
1.8
9.2
215
1459
U07.2
ICD-10 Finland
COVID-19, virus not identified
2.7
9.1
63
251
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.0
9.0
13
7
Z71.8
ICD-10 Finland
Other specified counselling
2.0
8.8
124
700
H02AB07
ATC
prednisone; oral
2.3
8.8
90
443
ZXA00
NOMESCO Finland
Right side
1.9
8.8
151
917
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.8
8.7
28
61
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
8.7
54
202
ZXA05
NOMESCO Finland
Left side
1.9
8.7
146
883
K50.9
ICD-10 Finland
Crohn disease, unspecified
10.3
8.6
16
16
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
20.4
8.5
12
6
E34.0
ICD-10 Finland
Carcinoid syndrome
91.5
8.4
9
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.3
8.4
83
400
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
13.0
8.4
14
11
K22.1
ICD-10 Finland
Ulcer of oesophagus
5.4
8.4
24
46
B01AB10
ATC
tinzaparin; parenteral
3.6
8.4
36
104
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.4
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.4
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
8.4
8
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
8.3
49
178
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.9
8.3
33
89
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.0
8.3
32
84
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
8.3
87
434
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
8.3
70
313
A07EA06
ATC
budesonide; oral, local oral
4.6
8.2
27
61
C03CA01
ATC
furosemide; systemic
1.8
8.1
172
1118
N03AX16
ATC
pregabalin; oral
1.9
8.1
134
803
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
7.9
96
509
D50.8
ICD-10 Finland
Other iron deficiency anaemias
9.6
7.8
15
16
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
7.8
49
185
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
45.7
7.7
9
*
K92.1
ICD-10 Finland
Melaena
3.3
7.7
38
123
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
8.2
7.6
16
20
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.8
7.6
24
52
JFB30
NOMESCO Finland
Right hemicolectomy
25.4
7.6
10
*
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
9.1
7.6
15
17
G44.2
ICD-10 Finland
Tension-type headache
2.2
7.6
76
371
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
7.6
105
587
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
7.6
47
175
A02BC03
ATC
lansoprazole; oral
1.8
7.6
170
1122
A98
ICPC
Health maint/preventive medicine
0.5
7.5
394
4421
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
4.2
7.5
27
67
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
81.2
7.4
8
*
6402
FHL
Small bowel resection
81.2
7.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
81.2
7.4
8
*
JFA73
NOMESCO Finland
Excision of lesion of small intestine
81.2
7.4
8
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
7.4
230
1675
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
7.3
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
K29.1
ICD-10 Finland
Other acute gastritis
6.4
7.3
18
29
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
16.0
7.3
11
7
KCD02
NOMESCO Finland
Transurethral resection of bladder
30.5
7.2
9
*
S01BC05
ATC
ketorolac; ophthalmic
3.5
7.1
32
97
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.0
7.1
14
16
JN4AD
NOMESCO Finland
Body CT examination
3.5
7.1
31
92
A07AA02
ATC
nystatin; oral
2.8
7.0
45
173
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
7.0
35
115
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
7.0
104
597
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.9
154
1010
Z51.5
ICD-10 Finland
Palliative care
4.9
6.9
21
44
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.9
152
993
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
9.5
6.8
13
14
3AC01
NOMESCO Finland
NA
9.5
6.8
13
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
6.8
218
1586
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
40.6
6.8
8
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
6.8
131
822
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.6
6.7
29
85
R03BA02
ATC
budesonide; inhalant
2.0
6.7
95
534
XW000
NOMESCO Finland
Bone marrow biopsy
4.3
6.7
23
55
JN4CD
NOMESCO Finland
Very extensive body CT
6.6
6.7
16
25
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.0
6.7
17
29
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.5
6.6
52
224
UJK02
NOMESCO Finland
ERCP
4.9
6.6
20
42
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
5.2
6.6
19
38
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
6.5
60
281
ZXE00
NOMESCO Finland
One hour or less
1.7
6.5
190
1344
RD210
NOMESCO Finland
NA
5.8
6.5
17
30
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
70.7
6.4
7
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
6.4
30
94
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
14.5
6.4
10
7
N05CF01
ATC
zopiclone; oral
1.7
6.4
172
1189
J01MA14
ATC
moxifloxacin; systemic
2.5
6.3
50
216
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
9.4
6.3
12
13
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.4
6.3
21
49
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.3
81
439
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
6.3
69
350
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
B88.0
ICD-10 Finland
Other acariasis
27.0
6.2
8
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
6.2
31
102
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.1
6.2
18
36
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.5
6.2
27
80
R4190
NOMESCO Finland
Nutritional therapy
4.8
6.2
19
41
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
6.1
27
81
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
12.7
6.1
10
8
JF1BD
NOMESCO Finland
Very extensive small bowel CT
12.7
6.1
10
8
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
10.2
6.1
11
11
K56.0
ICD-10 Finland
Paralytic ileus
10.2
6.1
11
11
B01AB04
ATC
dalteparin; parenteral
3.2
6.0
30
99
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
138
242
7.25
79.52
3.9
1.4
ug/l
6.1
4.8
0.22
118
186
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
52
22
25.97
73.41
6.5
1.7
nmol/l
10.4
3.8
0.70
52
22
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
69
98
7.90
47.25
4.2
1.8
u/ml
68.1
128.5
0.31
57
79
(4035726)
71
132
6.02
37.48
1.5
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
370
2168
3.11
35.28
9.1
3.6
umol/l
11.6
11.3
0.21
360
2029
(3030467) Casts [#/volume] in Urine by Automated count
243
1183
2.87
31.78
5.0
2.9
e6/l
0.4
0.4
0.25
192
880
(36304419) Bacteria [Presence] in Urine
238
1148
2.88
31.65
4.7
2.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
1333
2.83
31.42
4.5
2.6
u/l
33.4
31.9
0.27
249
1263
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
150
569
3.24
30.48
3.8
2.4
%
19.0
23.6
4.36
134
477
(3004789) Transferrin [Mass/volume] in Serum or Plasma
156
612
3.15
29.89
3.7
2.3
g/l
2.4
2.3
0.65
150
561
(40768797) Stomach Pathology biopsy report
163
665
3.05
29.08
1.5
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
166
688
3.01
28.76
3.8
2.2
umol/l
11.0
13.3
4.40
156
625
(3002582) Erythrocytes [#/volume] in Urine
249
1293
2.68
27.88
5.1
3.0
e6/l
28.4
99.1
0.78
205
995
(3026782) Osmolality of Urine
186
838
2.83
27.46
3.3
2.6
mosm/kgh2o
520.2
540.8
0.58
162
708
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
125
453
3.27
27.13
2.9
2.3
umol/l
11.1
6.7
0.87
113
392
(3044640) Blood type and Crossmatch panel - Blood
237
1226
2.63
26.42
3.6
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
357
2249
2.64
26.26
9.2
5.3
mmol/l
1.2
1.2
0.16
333
1911
(3019069) Monocytes/100 leukocytes in Blood
328
1988
2.58
26.11
7.4
5.8
%
8.4
8.6
0.61
310
1842
(3006504) Eosinophils/100 leukocytes in Blood
327
1983
2.58
25.94
7.2
5.5
%
2.8
3.0
0.58
311
1826
(3018095) Leukocytes [#/volume] in Urine
272
1528
2.53
25.19
5.7
3.5
e6/l
167.6
88.6
0.38
209
1068
(3002030) Lymphocytes/100 leukocytes in Blood
328
2021
2.52
24.70
7.3
5.7
%
27.5
27.5
0.04
310
1860
(3018010) Neutrophils/100 leukocytes in Blood
325
2003
2.50
24.33
7.3
5.4
%
57.4
57.6
0.09
304
1850
(3012095) Magnesium [Moles/volume] in Serum or Plasma
148
628
2.85
24.08
3.8
2.5
mmol/l
0.8
0.8
0.66
138
571
(3022096) Basophils/100 leukocytes in Blood
315
1921
2.48
24.03
7.2
5.6
%
0.7
0.7
0.09
298
1772
(3002032) Base excess in Venous blood by calculation
113
421
3.11
23.16
5.3
3.0
mmol/l
2.0
2.3
0.38
96
330
(3024561) Albumin [Mass/volume] in Serum or Plasma
312
1917
2.43
23.09
7.3
3.5
g/l
34.9
35.5
1.08
300
1768
(3013650) Neutrophils [#/volume] in Blood by Automated count
360
2363
2.48
22.90
12.0
6.2
e9/l
4.2
4.2
0.01
312
2039
(42870588) Differential panel, method unspecified - Blood
251
1415
2.41
22.36
5.9
5.5
—
—
—
0
0
(3012544) pH of Venous blood
114
442
2.99
21.69
5.2
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
674
2.68
21.59
3.9
2.7
e6/l
2.5
3.0
0.24
89
340
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
456
3421
2.85
20.74
11.8
5.3
u/l
86.0
75.3
3.71
443
3132
(3021589) Normoblasts [#/volume] in Blood
305
1914
2.31
20.71
12.0
8.2
e9/l
0.0
0.0
0.33
246
1559
(3032080) INR in Blood by Coagulation assay
299
1863
2.31
20.62
11.0
9.7
inr
1.4
1.3
0.39
45
514
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
100
371
3.07
20.50
3.3
1.9
u/l
41.0
33.5
0.50
88
297
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
184
936
2.44
20.24
4.4
4.0
ng/l
58.0
367.5
3.42
150
767
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
246
1428
2.30
19.89
3.8
2.1
u/l
59.5
57.0
0.42
236
1300
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
155
737
2.53
19.65
3.7
2.5
e6/l
3.0
1.3
1.21
93
402
(3000850) Epithelial cells [#/volume] in Urine
178
906
2.42
19.43
4.0
2.4
e6/l
5.2
6.6
0.52
166
795
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
92
339
3.05
19.01
2.5
1.9
g/l
0.2
0.2
1.73
83
301
(3000330) Specific gravity of Urine by Test strip
78
262
3.30
18.82
5.1
3.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
184
962
2.36
18.81
8.9
4.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
324
2138
2.24
18.81
6.9
5.3
e9/l
0.6
0.6
0.45
272
1832
(3006315) Basophils [#/volume] in Blood
325
2149
2.23
18.75
6.9
5.3
e9/l
0.0
0.0
0.28
273
1849
(3000991) Gas panel - Venous blood
91
336
3.04
18.73
7.2
6.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
332
2225
2.22
18.38
7.6
5.6
e9/l
0.2
0.2
0.30
287
1936
(3023368) Bacteria identified in Blood by Culture
204
1124
2.29
18.37
5.9
3.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
327
2184
2.21
18.18
7.0
5.4
e9/l
1.9
1.8
0.21
282
1897
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
182
962
2.33
18.02
2.7
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
296
1908
2.18
17.92
5.3
3.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
104
431
2.74
17.24
3.5
3.3
ng/l
191.7
201.6
0.10
96
399
(3013826) Glucose [Moles/volume] in Serum or Plasma
372
2652
2.22
17.07
6.2
4.0
mmol/l
6.9
6.7
1.19
355
2479
(3002256) Pathology report gross observation
83
309
2.98
16.76
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
49
132
3.97
16.39
4.3
5.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
91
363
2.80
16.18
9.7
5.6
mmol/l
11.2
10.5
0.34
86
341
(3003458) Phosphate [Moles/volume] in Serum or Plasma
123
571
2.48
16.10
7.6
4.1
mmol/l
1.0
1.0
0.07
114
505
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
204
1178
2.16
15.91
3.3
2.1
mg/l
3.5
3.0
1.33
184
973
(3015736) pH of Urine
270
1773
2.02
14.56
4.8
3.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
73
4.74
14.18
3.1
2.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
103
477
2.42
13.38
3.0
2.1
ug/g
161.2
143.7
0.23
89
367
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
15
10.25
13.18
1.1
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
302
2113
1.94
13.05
2.2
2.0
pmol/l
89.1
95.4
1.29
156
1032
(40768804) Tissue Pathology biopsy report
221
1397
1.97
12.87
2.4
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
299
2.66
12.22
2.4
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
273
1890
1.87
11.77
4.6
2.6
ug/l
103.3
124.8
1.55
261
1699
(3018418) pH of Serum or Plasma
207
1311
1.92
11.76
4.7
3.0
ph
7.4
7.4
—
8
218
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
15
9.55
11.70
1.2
1.9
%
14.3
12.7
—
6
7
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
49
165
3.16
11.69
3.0
1.7
ug/l
5.1
2.1
0.56
39
141
(4094501)
42
129
3.44
11.60
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
21
7.82
11.47
1.9
1.7
e9/l
1.2
0.9
—
9
11
(3009261) Glucose [Presence] in Urine by Test strip
312
2269
1.85
11.35
4.9
3.8
estimate
0.0
0.0
0.50
19
370
(3027801) Oxygen [Partial pressure] in Arterial blood
104
526
2.20
10.87
8.0
5.8
kpa
12.2
11.5
0.64
97
509
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
104
526
2.20
10.87
8.0
5.8
kpa
5.1
5.1
0.00
96
509
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
51
4.87
10.81
5.8
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
103
527
2.17
10.44
8.1
5.8
mmol/l
1.1
1.6
0.65
85
413
(3035350) Ketones [Presence] in Urine by Test strip
304
2233
1.80
10.32
4.8
3.8
estimate
0.0
0.0
0.00
18
379
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
58
230
2.70
10.32
7.9
7.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
305
2243
1.80
10.31
8.3
5.2
estimate
0.0
0.0
0.00
20
371
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
358
2764
1.83
10.26
3.9
2.9
u/l
58.7
45.2
1.46
339
2533
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
426
2.27
10.20
4.2
3.1
u/l
237.4
242.4
0.19
83
399
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
282
2047
1.77
9.78
7.7
4.7
mmol/l
1.2
1.2
1.09
259
1801
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
392
2.28
9.78
4.3
3.5
ng/l
123.5
82.2
2.08
70
338
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
50
193
2.75
9.36
1.6
1.6
g/l
1.6
1.5
0.33
42
166
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
64
281
2.44
9.24
3.2
2.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
93
479
2.13
9.21
8.1
5.9
%
95.0
95.2
0.11
87
463
(3005719) IgG [Mass/volume] in Serum or Plasma
64
282
2.43
9.16
1.8
2.4
g/l
9.4
11.0
2.41
58
259
(3015377) Calcium [Moles/volume] in Serum or Plasma
221
1518
1.76
9.12
4.2
2.1
mmol/l
2.3
2.4
0.71
196
1242
(3037467) Urinalysis macro (dipstick) panel - Urine
389
3134
1.80
9.09
6.1
4.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
435
3633
1.91
8.96
35.5
15.4
%
14.1
13.7
2.83
425
3531
(3036603) Volume of Urine
16
28
5.85
8.85
1.3
1.6
ml
1767.1
2146.4
—
9
7
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
60
262
2.45
8.76
2.0
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
156
982
1.82
8.57
2.5
1.6
mg/l
1.0
1.1
0.15
133
756
(3027945) Reticulocytes/100 erythrocytes in Blood
98
535
2.01
8.27
2.9
2.3
%
1.8
1.8
0.24
88
472
(3028026) IgM [Mass/volume] in Serum or Plasma
53
227
2.48
8.06
1.5
1.4
g/l
1.0
1.2
1.35
48
210
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
60
3.96
8.05
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
464
4005
1.96
8.02
32.6
14.1
%
37.3
39.5
3.99
300
2601
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
116
3.06
7.95
1.4
1.4
ug/g
279.8
309.8
0.48
23
65
(3022145) Colonoscopy Study observation
87
468
2.02
7.62
1.5
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
12
8.47
7.60
2.4
1.5
e9/l
0.0
0.2
—
10
12
(3052851) Hemolysis interference index of Serum or Plasma
35
126
2.90
7.47
3.3
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
129
803
1.79
7.22
1.5
1.3
g/l
2.4
2.6
0.46
79
462
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
118
2.91
7.13
2.6
2.5
u/ml
0.4
0.4
0.02
19
68
(3025159) Blasts/100 leukocytes in Blood
62
303
2.18
6.98
4.0
4.3
%
0.1
1.6
—
10
57
(3017181) Myelocytes/100 leukocytes in Blood
66
332
2.12
6.91
4.3
4.1
%
0.2
0.9
2.62
12
72
(3007853) Bacteria identified in Skin by Aerobe culture
84
462
1.96
6.89
2.3
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
499
4482
2.11
6.76
28.0
12.8
mg/l
25.4
22.8
1.08
432
3442
(3019150) Specific gravity of Urine by Refractometry
158
1059
1.69
6.75
4.5
4.2
kg/l
1.0
1.0
1.33
73
156
(3021440) Promyelocytes/100 leukocytes in Blood
63
315
2.13
6.69
4.5
4.2
%
0.0
0.1
1.35
12
63
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
258
1958
1.59
6.67
2.7
2.3
nmol/l
80.1
79.2
0.19
241
1693
(3042936) Bacteria identified in Isolate by Culture
103
614
1.83
6.61
2.6
1.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
46
4.01
6.48
1.1
1.2
u/ml
3.6
3.6
—
5
14
(3025941) Bacteria identified in Stool by Culture
49
224
2.30
6.47
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
66
3.43
6.34
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
15
34
4.51
6.27
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
99
2.93
6.19
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
204
1485
1.59
6.17
3.7
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
512
1.85
6.08
2.2
1.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
20
5.59
5.82
1.5
2.4
u/l
183.5
208.3
0.56
11
20
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
177
2.36
5.70
1.6
1.3
g/l
10.0
10.8
0.44
35
150
(3041096) Erythrocytes [Presence] in Urine by Automated
166
1169
1.60
5.70
5.6
3.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
56
3.48
5.63
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
56
3.48
5.63
1.2
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
404
3474
1.60
5.60
5.5
4.3
mm/h
14.2
12.8
1.04
388
3170
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
96
590
1.76
5.52
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
142
2.49
5.49
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
97
600
1.75
5.45
1.4
1.4
titre
400.0
576.2
0.56
17
151
(3030981) Hyaline casts [#/volume] in Urine by Automated count
48
234
2.15
5.45
3.1
2.6
e6/l
0.3
0.2
0.21
48
224
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
516
1.79
5.36
2.2
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
18
5.64
5.34
5.5
3.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
22
5.08
5.28
2.7
1.3
ug/l
14.6
15.8
0.16
11
22
(42529406) Shigella sp [Presence] in Stool by Culture
34
145
2.43
5.26
1.3
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
191
2.24
5.21
1.6
1.4
g/l
7.1
7.6
0.79
23
139
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
191
2.24
5.21
1.6
1.4
g/l
3.4
3.9
1.19
23
135
(3016228) CD19 cells/100 cells in Blood
8
6
13.50
5.09
1.4
2.0
%
2.6
4.3
—
8
6
(21494814) CD8 cells/100 lymphocytes in Specimen
8
6
13.50
5.09
1.4
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
135
2.45
5.07
2.9
2.4
ug/min
10.2
84.2
2.25
26
75
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
154
2.36
5.07
1.8
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
123
2.52
5.05
1.4
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
82
2.88
5.04
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
82
2.88
5.04
1.4
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
142
2.41
5.02
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
169
1227
1.54
4.98
1.7
1.5
nmol/l
20.3
21.4
0.48
155
1020
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
51
3.41
4.92
1.1
1.2
u/ml
2.4
9.1
—
7
23
(3019309) Folate [Moles/volume] in Red Blood Cells
145
1024
1.56
4.82
1.6
1.8
nmol/l
925.1
1215.9
4.74
122
746
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
191
2.18
4.80
1.6
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
7
11.57
4.79
1.0
3.0
—
—
—
0
0
(3035880) pH of Pleural fluid
10
20
5.07
4.79
1.1
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
47
3.48
4.78
2.4
2.0
—
377.4
—
0
5
(3000494) Fungus identified in Specimen by Culture
83
510
1.74
4.76
1.7
1.4
—
—
—
0
0
(3013512) EKG study
195
1472
1.50
4.75
6.3
4.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
735
1.62
4.60
2.2
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
5
14.15
4.58
1.1
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
68
403
1.78
4.42
2.2
2.6
e9/l
72.5
68.6
0.36
50
312
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
55
3.16
4.39
1.1
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
131
924
1.55
4.33
5.8
4.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
126
886
1.55
4.22
3.8
2.1
mmol/l
2.5
2.4
1.15
109
765
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
103
2.49
4.19
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
27
4.14
4.18
1.5
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
57
3.04
4.15
1.3
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
23
4.41
4.10
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
201
1563
1.45
4.09
3.1
2.9
ng/l
1895.6
1337.5
0.58
182
1317
(4306422)
15
47
3.25
4.08
1.1
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
37
186
2.06
3.93
1.2
1.1
—
105.2
—
0
5
(3034770) Mitochondria Ab [Titer] in Serum
26
113
2.36
3.91
1.3
1.2
—
842.0
—
0
5
(4211845)
10
24
4.22
3.90
5.5
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
159
1192
1.47
3.88
3.5
2.3
umol/l
7964.7
6300.3
0.14
143
1008
(3039162) Centromere protein B Ab [Units/volume] in Serum
19
71
2.74
3.86
1.1
1.3
—
75.1
—
0
5
(3025130) Human papilloma virus identified in Specimen
11
29
3.85
3.82
1.4
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
134
2.23
3.80
1.3
1.6
iu/ml
0.1
0.1
—
10
24
(3021901) Oxygen saturation in Capillary blood
20
78
2.62
3.76
3.4
3.0
—
—
—
0
0
(4268621)
12
35
3.48
3.63
1.8
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
146
1092
1.46
3.58
3.5
3.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
63
2.75
3.52
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
216
1738
1.40
3.52
5.6
4.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
58
2.81
3.45
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
953
1.46
3.35
1.3
1.2
u/ml
0.6
1.9
1.85
40
252
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
373
1.68
3.32
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
207
1.90
3.26
1.1
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
66
2.63
3.24
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
145
1102
1.43
3.23
1.7
1.8
pmol/l
76562982.1
13190972.1
0.38
128
887
(3047189) Immunofixation for 24 hour Urine
7
11
6.43
3.19
1.1
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
338
1.70
3.18
1.5
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
401
3605
1.40
3.17
4.6
4.0
pmol/l
14.5
15.0
3.59
377
3239
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
672
0.56
3.11
7.4
7.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
80
2.42
3.09
1.4
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
16
5.06
3.06
2.1
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
31
161
1.98
3.06
1.3
1.7
g/l
1.3
1.2
0.97
26
153
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
463
4282
1.49
3.05
23.4
11.7
ml/min/173m2
74.7
76.1
0.74
421
3416
(40761536) Microorganisms panel - Urine sediment
15
348
0.42
3.01
4.6
3.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
51
2.79
3.00
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
87
1204
0.67
2.95
4.5
4.1
estimate
0.0
0.0
0.50
19
366
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
32
171
1.92
2.92
1.1
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
68
452
1.57
2.90
1.8
1.5
—
—
—
0
0
(4281824)
9
22
4.14
2.89
1.3
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
657
0.58
2.86
3.6
5.0
%
34.3
33.0
0.25
25
412
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
130
2.05
2.85
1.7
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
77
2.38
2.84
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
210
1.82
2.82
1.4
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.39
2.75
1.0
1.2
%
118.6
106.3
—
5
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.39
2.75
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
92
2.22
2.70
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
92
2.22
2.70
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
19
4.26
2.68
1.3
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
19
4.26
2.68
1.3
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
24
3.79
2.68
2.7
3.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
99
2.17
2.68
2.2
2.3
—
—
—
0
0
(3000492) Spirometry study
57
371
1.60
2.67
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
275
2373
1.31
2.61
2.9
2.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
11
5.50
2.55
4.3
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
115
2.04
2.54
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
506
4806
1.59
2.53
31.6
15.5
mmol/l
3.9
4.0
2.65
496
4655
(3019550) Sodium [Moles/volume] in Serum or Plasma
505
4795
1.58
2.52
31.6
15.4
mmol/l
139.7
139.8
0.37
497
4652
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
16
4.42
2.48
1.0
1.1
u/l
10.6
21.1
—
7
11
(3006462) Nitrate [Presence] in Urine
8
21
3.85
2.47
4.8
4.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
16
70
2.32
2.43
1.1
1.4
pmol/l
113.9
62.9
0.69
16
70
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
45
283
1.64
2.43
2.0
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
308
1.61
2.39
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
98
2.08
2.34
1.2
1.2
—
—
—
0
0
(4062490)
10
35
2.89
2.31
1.2
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
7
18
3.92
2.26
1.0
1.1
u/l
68.3
81.3
—
7
13
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
43
273
1.62
2.25
3.8
3.7
mmol/l
2.4
2.1
0.19
33
208
(40761511) CBC panel - Blood by Automated count
495
4700
1.48
2.24
25.4
12.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
73
2.23
2.23
2.1
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.59
2.22
1.0
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
25
136
1.88
2.21
2.4
1.3
mg/l
49.3
29.8
0.58
25
110
(3051611) Lipemic interference index of Serum or Plasma
11
42
2.65
2.19
5.4
3.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
23
122
1.92
2.19
2.0
1.6
e6/l
3705.2
15490.1
2.04
18
88
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
108
1.98
2.18
1.4
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
25
137
1.86
2.17
2.4
1.3
mg/l
51.8
42.3
0.41
25
111
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
30
3.03
2.15
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
37
2.73
2.11
1.2
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
19
96
2.01
2.07
1.8
2.3
umol/l
33.4
32.8
0.03
14
85
(3022806) Fractional oxyhemoglobin in Capillary blood
0
56
0.00
2.07
0.0
1.7
—
90.0
—
0
56
(3019060) Gas panel - Arterial blood
48
320
1.55
2.06
8.7
4.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
15
4.03
2.04
1.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
111
1.93
2.03
1.8
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
24
133
1.84
2.02
2.4
1.3
—
1.2
—
0
15
(21494890) Protein electrophoresis panel - 24 hour Urine
10
38
2.66
2.02
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
454
4268
1.35
1.99
5.7
4.9
mu/l
1.9
2.3
0.61
436
3837
(3049717) Cytology report of Urine Cyto stain
24
136
1.80
1.90
2.8
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
505
4840
1.47
1.90
16.2
9.2
u/l
26.0
24.3
1.49
499
4611
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
129
1.82
1.88
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
34
2.67
1.87
1.1
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
46
2.42
1.86
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
176
1.68
1.83
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
177
1.67
1.80
1.8
1.4
g/l
3.4
3.1
0.54
23
137
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
220
1914
1.25
1.76
4.3
3.8
ng/l
26.3
55.1
0.98
160
1408
(3019230) Fractional oxyhemoglobin in Venous blood
16
81
2.00
1.76
3.4
1.7
%
58.5
60.3
0.10
16
81
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
18
3.36
1.75
2.5
1.7
ug/l
34.0
55.4
—
6
18
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
18
3.36
1.75
3.7
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
36
2.52
1.74
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
89
1.94
1.71
1.5
1.3
mmol/l
61.3
64.4
—
10
75
(3002179) Metamyelocytes/100 leukocytes in Blood
45
310
1.49
1.70
4.0
4.2
%
0.2
0.4
—
6
59
(40760888) Immunoglobulin light chains.free panel - Serum
18
97
1.88
1.68
1.5
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
31
2.60
1.66
1.4
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
43
2.35
1.61
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
57
2.13
1.56
1.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
65
2.02
1.49
1.2
1.3
nmol/l
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
22
2.75
1.44
1.3
1.2
mmol/l
6.0
6.9
—
6
22
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
40
2.27
1.40
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
354
3287
1.21
1.38
4.2
4.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
97
1.78
1.36
2.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
818
1.27
1.34
1.3
1.3
iu/ml
28.3
35.4
0.42
26
255
(3004588) Protein electrophoresis panel - Serum or Plasma
45
327
1.41
1.33
1.7
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
6
24
2.52
1.30
2.0
2.3
—
147.2
—
0
5
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
44
2.06
1.27
2.6
2.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
81
650
1.29
1.27
32.4
27.4
inr
1.3
1.3
—
5
93
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
25
2.41
1.24
1.2
2.7
u/ml
435.0
1285.8
—
6
25
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
26
172
1.54
1.23
1.5
1.7
—
177.5
—
0
8
(36660697) Celiac disease serology panel - Serum
45
334
1.38
1.19
1.2
1.2
—
—
—
0
0
(44806118)
8
38
2.12
1.19
1.4
1.3
—
—
—
0
0
(44790048)
8
38
2.12
1.19
1.4
1.3
—
—
—
0
0
(44790047)
8
38
2.12
1.19
1.4
1.3
—
—
—
0
0
(44790049)
8
38
2.12
1.19
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
79
1.79
1.18
1.1
1.3
miu/ml
135.9
231.0
—
5
33
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
39
2.07
1.15
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
258
0.61
1.15
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
58
1.91
1.12
1.5
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
58
1.91
1.12
1.5
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
58
1.91
1.12
1.4
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
26
177
1.49
1.10
2.7
2.1
ug/l
354.5
539.0
0.26
26
162
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
21
2.39
1.09
1.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
33
2.14
1.06
1.9
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
151
1326
1.19
1.04
5.6
3.9
ug/l
2.7
2.0
0.47
136
1165
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
22
2.28
1.03
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
115
985
1.21
1.03
1.4
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.02
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
35
2.01
1.00
1.3
1.5
%
9.7
10.2
—
7
35
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
76
1.73
0.99
1.8
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
23
2.18
0.98
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
94
794
1.22
0.97
1.4
1.3
u/ml
12.0
14.6
0.13
44
281
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
51
1.78
0.95
1.1
2.4
pg
31.6
33.0
—
9
51
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
303
0.68
0.94
2.2
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
143
1.49
0.91
1.8
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
142
1597
0.85
0.91
3.4
3.0
mmol/l
6.7
7.2
0.90
125
1317
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
42
1.92
0.89
1.1
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
56
1.80
0.88
1.5
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
512
5004
1.29
0.88
40.2
18.9
fl
91.2
91.4
0.43
505
4904
(3007461) Platelets [#/volume] in Blood
512
5005
1.29
0.87
40.3
19.0
e9/l
243.9
248.3
0.82
500
4844
(3035941) MCH [Entitic mass]
512
5005
1.29
0.87
40.1
18.9
pg
30.3
30.4
0.61
505
4905
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
64
1.73
0.86
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
512
5006
1.29
0.85
40.2
19.0
e12/l
4.3
4.5
8.49
498
4824
(3010813) Leukocytes [#/volume] in Blood
512
5006
1.29
0.85
40.2
19.0
e9/l
6.9
6.6
1.24
497
4823
(3017732) Neutrophils [#/volume] in Blood
38
292
1.32
0.85
2.4
2.9
e9/l
4.1
4.0
0.15
28
209
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
14
88
1.61
0.85
1.1
1.2
u/l
69.7
17.4
0.57
14
79
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
57
1.77
0.84
1.5
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
57
1.77
0.84
6.2
2.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
57
1.77
0.84
1.5
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
512
5008
1.28
0.83
40.5
19.1
g/l
129.3
134.8
13.33
507
4907
(1616796) Gas panel - Central venous blood
12
73
1.66
0.82
4.2
3.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
32
1.88
0.82
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
33
1.83
0.79
1.7
1.3
u/l
12.9
39.2
—
6
23
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
122
0.57
0.78
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
84
722
1.19
0.75
2.7
2.7
ug/l
0.8
0.8
0.01
66
485
(3022313) Gas panel - Capillary blood
29
219
1.34
0.75
3.3
3.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
171
0.64
0.73
2.2
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
92
1.54
0.73
1.9
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
25
2.01
0.73
1.0
1.6
—
—
—
0
0
(44813793)
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
25
2.01
0.73
1.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
60
1.68
0.72
1.5
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
60
1.68
0.72
1.1
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
36
284
1.29
0.70
1.0
1.2
iu/ml
166.9
120.8
0.26
16
111
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
69
1.61
0.69
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
241
1.30
0.67
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
453
4401
1.16
0.66
7.9
6.3
mmol/mol
41.2
40.3
1.22
437
4036
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
305
1.26
0.65
4.0
3.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
121
1.42
0.63
1.5
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
80
1.51
0.60
1.3
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
197
0.70
0.60
1.7
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
1294
0.88
0.59
1.7
1.7
mmol/l
1.4
1.3
0.65
101
1063
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
2.3
—
50.3
—
0
16
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
35
1.72
0.58
1.0
1.6
—
26.4
—
0
7
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
54
1.49
0.57
1.5
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
8
54
1.49
0.57
1.3
1.0
—
2.1
—
0
19
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
73
1.52
0.56
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
126
0.63
0.55
2.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
55
471
1.19
0.54
1.6
2.5
ug/l
4.4
6.9
1.56
49
404
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
61
1.48
0.54
1.0
1.1
—
188.1
—
0
8
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
74
1.50
0.53
1.5
1.6
mu/l
465.6
274.3
0.95
11
67
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
41
1.47
0.50
1.3
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
399
0.82
0.50
4.5
3.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
84
1.44
0.49
1.3
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
39
327
1.21
0.49
2.1
2.5
—
20.7
—
0
7
(3014051) Protein [Presence] in Urine by Test strip
7
111
0.63
0.48
2.3
2.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
81
0.61
0.46
1.8
3.3
%
54.4
59.7
—
5
81
(3019832) Treponema pallidum Ab [Presence] in Serum
23
185
1.25
0.42
1.6
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
57
1.41
0.42
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
6.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.3
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.4
1.2
u/ml
0.1
1.0
—
5
22
(1761868) Lipid panel - Serum or Plasma
161
1513
1.09
0.39
4.2
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
41
355
1.17
0.38
2.7
2.1
ml/min/173m2
61.3
64.2
0.25
24
147
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
5.2
—
0
8
(4010399)
41
356
1.16
0.37
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
42
480
0.86
0.37
4.3
3.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
623
1.12
0.36
1.6
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
79
0.63
0.35
1.8
2.9
e9/l
2.6
4.3
—
5
79
(3016018) Differential panel - Cerebral spinal fluid
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
44
1.37
0.34
1.3
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
83
1.33
0.32
1.5
1.9
nmol/l
39.6
43.1
0.16
11
78
(3037121) Protein [Mass/volume] in Urine
18
147
1.23
0.31
3.8
2.3
g/l
0.4
0.2
0.23
13
41
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
195
1.19
0.28
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
468
4615
1.09
0.28
5.2
4.9
mmol/l
6.2
6.0
2.61
448
4133
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
85
1.30
0.28
1.8
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
415
0.88
0.27
2.2
1.7
%
1.4
1.5
0.83
32
347
(3021788) Differential panel - Synovial fluid
12
95
1.27
0.26
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
88
1.26
0.22
3.9
2.3
%
15.8
16.2
0.20
11
39
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
210
0.85
0.22
1.7
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(4034850)
19
163
1.17
0.22
13.1
10.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
6.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
1.7
—
0
12
(4198724)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
14
0.00
0.20
0.0
6.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
19
166
1.15
0.18
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
456
4606
0.94
0.18
4.8
4.8
mmol/l
4.5
4.6
1.47
435
4181
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
79
1.14
0.15
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
234
0.89
0.15
1.6
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
90
0.78
0.14
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
138
0.87
0.13
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
182
1.10
0.11
2.0
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
454
4571
0.96
0.10
4.8
4.8
mmol/l
1.4
1.5
4.57
431
4127
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
116
1.12
0.09
1.8
1.6
iu/l
1.9
5.0
—
5
43
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
444
4412
1.03
0.09
4.4
4.3
mmol/l
1.3
1.3
0.95
419
3941
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
63
0.79
0.08
1.2
1.4
u/l
13.2
10.3
—
5
54
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
74
0.81
0.07
4.8
2.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
468
0.96
0.07
1.7
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
469
4710
0.97
0.06
5.5
5.4
mmol/l
2.6
2.7
0.80
444
4264
(3012516) Albumin [Mass/volume] in Urine
153
1553
0.98
0.06
3.5
3.1
mg/l
2261.0
223.6
1.42
98
942
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
108
1062
1.02
0.05
5.0
3.7
%
23.0
24.0
0.26
60
503
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
120
1.09
0.05
1.8
2.3
mg/l
12.6
12.4
0.03
13
113
(3020891) Body temperature
18
189
0.95
0.03
14.1
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
440
0.98
0.02
4.0
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
208
0.96
0.02
1.5
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
166
1651
1.01
0.01
4.0
3.9
mg/mmol
16.9
7.7
0.84
109
998
(3001019) Free T4 and TSH panel - Serum or Plasma
15
155
0.97
0.00
1.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
174
0.98
0.00
1.8
1.6
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
50
1.00
0.00
4.0
4.2
mmol/l
6.1
7.2
—
5
39
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.3
—
0.7
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
61
0.98
0.00
3.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
63
0.95
0.00
2.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
29
290
1.00
0.00
1.3
1.4
—
49.6
—
0
15
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SMALL_INTESTINE_OTH_EXALLC – Benign neoplasm: Other and unspecified parts of small intestine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).